|
Nov 9
|
Earnings Beat: Here's What ADMA Biologics, Inc. (NASDAQ:ADMA) Analysts Are Forecasting For Next Year
|
|
Nov 8
|
Q3 2024 ADMA Biologics Inc Earnings Call
|
|
Nov 8
|
ADMA Biologics Inc (ADMA) Q3 2024 Earnings Call Highlights: Record Revenue and Net Income Surge
|
|
Nov 8
|
Adma Biologics (ADMA) Q3 Earnings and Revenues Beat Estimates
|
|
Nov 7
|
Adma Biologics: Q3 Earnings Snapshot
|
|
Nov 7
|
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update
|
|
Nov 7
|
3 High Growth Tech Stocks Leading The US Market
|
|
Nov 5
|
Should ADMA Biologics Stock Be in Your Portfolio Pre-Q3 Earnings?
|
|
Nov 4
|
Adma Biologics (ADMA) Soars 18.8%: Is Further Upside Left in the Stock?
|
|
Nov 4
|
3 US Stocks That May Be Trading Below Estimated Value
|
|
Sep 27
|
Biotech Hangs On To Top Spot On This List, And It Even Outshines Nvidia
|
|
Sep 27
|
ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal
|
|
Sep 26
|
Is ADMA Biologics Inc. (ADMA) the Best Performing Small-Cap Stock in 2024?
|
|
Sep 26
|
Adma Biologics (ADMA) Stock Sinks As Market Gains: Here's Why
|
|
Sep 26
|
Pfizer Withdraws Sickle Cell Disease Therapy Oxbryta From Market
|
|
Sep 6
|
Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
|
|
Aug 29
|
Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year?
|
|
Aug 29
|
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?
|
|
Aug 1
|
ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024
|
|
Jul 31
|
Adma Biologics (ADMA) Rises But Trails Market: What Investors Should Know
|